Related Experiment Video

Updated: Jul 12, 2026

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model
08:06

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model

Published on: November 26, 2010

Treatment of metastatic melanoma and renal cell carcinoma with interleukin-2

L A Manson

    JAMA
    |November 2, 1994
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Y-27632 Enriches the Yield of Human Melanocytes from Adult Skin Tissues
    08:06

    Y-27632 Enriches the Yield of Human Melanocytes from Adult Skin Tissues

    Published on: July 8, 2020

    Roller Microneedle Combined with Tranexamic Acid Solution in Treating Melasma
    04:12

    Roller Microneedle Combined with Tranexamic Acid Solution in Treating Melasma

    Published on: January 19, 2024

    Related Experiment Videos

    Last Updated: Jul 12, 2026

    Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model
    08:06

    Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model

    Published on: November 26, 2010

    Y-27632 Enriches the Yield of Human Melanocytes from Adult Skin Tissues
    08:06

    Y-27632 Enriches the Yield of Human Melanocytes from Adult Skin Tissues

    Published on: July 8, 2020

    Roller Microneedle Combined with Tranexamic Acid Solution in Treating Melasma
    04:12

    Roller Microneedle Combined with Tranexamic Acid Solution in Treating Melasma

    Published on: January 19, 2024

    Related Concept Videos

    Skin Cancer01:30

    Skin Cancer

    Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
    Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

    Articles linked to this work by shared authors, journal, and citation graph.

    Anti-tumor immune responses of the tumor-bearing host: the case for antibody-mediated immunologic enhancement.

    Clinical immunology and immunopathology·1994

    Does antibody-dependent epitope masking permit progressive tumour growth in the face of cell-mediated cytotoxicity?

    Immunology today·1991

    Novel tumor-specific antigen(s) response observed in a syngeneic lymphoma-bearing host.

    Cancer detection and prevention. Supplement : official publication of the International Society for Preventive Oncology, Inc·1987

    A subset of normal human B lymphocytes expresses an antigen cross-reactive with gp52 of murine mammary tumor virus.

    Cancer detection and prevention. Supplement : official publication of the International Society for Preventive Oncology, Inc·1987

    A viral coat glycoprotein (gp52MuMTV) has detergent-sensitive and detergent-resistant epitopes in the same molecule.

    Molecular immunology·1983

    Characterization of "H-2K,D-like structures" on MM2 x mouse L cell hybrids. II. An "H-2Kd-like" structure on C3H-derived tumor.

    International journal of cancer·1983

    Individualized Cardiac Index-Guided Hemodynamic Therapy in High-Risk Patients Undergoing Elective Major Abdominal Surgery: The PELICAN Randomized Clinical Trial.

    JAMA·2026

    A Common CD36 Variant and the Genetic Landscape of Dilated Cardiomyopathy in Individuals of African Ancestry.

    JAMA·2026

    Clinician Use of an Artificial Intelligence-Enabled Clinical Information Platform.

    JAMA·2026

    Pembrolizumab plus gemcitabine and cisplatin for advanced biliary tract cancer: longer-term follow-up from the randomised, double-blind, placebo-controlled, phase 3 KEYNOTE-966 trial.

    EClinicalMedicine·2026

    Correction: Sociodemographic and clinical predictors of malignancy in thyroid nodules: a systematic review and meta-analysis.

    Frontiers in endocrinology·2026

    Beyond combination: sequencing priming modalities before immune checkpoint inhibitors to convert immunologically cold tumors toward an ICI-responsive phenotype.

    Frontiers in immunology·2026

    A novel nanoparticle-based co-delivery system of Fritillaria persica L. extract and gemcitabine for inhibiting breast cancer progression.

    Beilstein journal of nanotechnology·2026

    Return to Work After Adjuvant Chemotherapy for Colon Cancer: A Retrospective Study With Exploratory Occupational Analysis.

    Cureus·2026

    Initiation of Smoking After Electroconvulsive Therapy in a Non-Smoker Patient with Major Depression: A Case Report.

    Addiction & health·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us